Literature DB >> 10350021

Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil.

V Merino1, A López, Y N Kalia, R H Guy.   

Abstract

PURPOSE: To delineate the contributions of electrorepulsion and electroosmosis to the iontophoretic flux of 5-FU across porcine skin in vitro. Also, the isoelectric point (pI) of the skin model was determined.
METHODS: The electrotransport of 5-FU, anode-to-cathode ("anodal") and cathode-to-anode ("cathodal") was determined as a function of the pH of the electrolyte bathing the skin.
RESULTS: At pH 8.5, the drug (pKa approximately 8) is negatively charged and "cathodal", viz. electrorepulsive, transport is much greater than that in the opposite direction. At pH 7.4, where approximately 25% of 5-FU is charged, electrorepulsive and electroosmotic ("anodal") fluxes are balanced. Decreasing the pH to 6, and then 5, reduces the percentage of ionized 5-FU such that "anodal" electroosmosis dominates across the negatively-charged membrane. But, at pH 4, "anodal" and "cathodal" fluxes are again equal suggesting neutralization of the skin (i.e., pI approximately 4). This is confirmed at pH 3, where "cathodal" electroosmosis dominates across the now net-positively charged barrier.
CONCLUSIONS: Electrotransport is sensitive, mechanistically, to the properties of the permeant and of the skin; interactions of, for example, the drug or constituents of a formulation, that alter the barrier's net charge, can affect iontophoretic delivery. The pI of porcine ear skin is approximately 4.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10350021     DOI: 10.1023/a:1018841111922

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro.

Authors:  P G Green; R S Hinz; C Cullander; G Yamane; R H Guy
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

2.  Transport mechanisms in iontophoresis. I. A theoretical model for the effect of electroosmotic flow on flux enhancement in transdermal iontophoresis.

Authors:  M J Pikal
Journal:  Pharm Res       Date:  1990-02       Impact factor: 4.200

3.  Transport mechanisms in iontophoresis. II. Electroosmotic flow and transference number measurements for hairless mouse skin.

Authors:  M J Pikal; S Shah
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

4.  A new system for in vitro studies of iontophoresis.

Authors:  P Glikfeld; C Cullander; R S Hinz; R H Guy
Journal:  Pharm Res       Date:  1988-07       Impact factor: 4.200

5.  Characterization of the permselective properties of excised human skin during iontophoresis.

Authors:  R R Burnette; B Ongpipattanakul
Journal:  J Pharm Sci       Date:  1987-10       Impact factor: 3.534

6.  Convective solvent flow across the skin during iontophoresis.

Authors:  A Kim; P G Green; G Rao; R H Guy
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

7.  Iontophoresis of poly-L-lysines: the role of molecular weight?

Authors:  N G Turner; L Ferry; M Price; C Cullander; R H Guy
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

8.  Iontophoretic permselectivity of mammalian skin: characterization of hairless mouse and porcine membrane models.

Authors:  A Luzardo-Alvarez; M Rodríguez-Fernández; J Blanco-Méndez; R H Guy; M B Delgado-Charro
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

  8 in total
  5 in total

1.  Iontophoretic delivery of 5-aminolevulinic acid (ALA): effect of pH.

Authors:  R F Lopez; M V Bentley; M B Delgado-Charro; R H Guy
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

2.  Contributions of electromigration and electroosmosis to iontophoretic drug delivery.

Authors:  D Marro; Y N Kalia; M B Delgado-Charro; R H Guy
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

3.  Local iontophoretic administration of cytotoxic therapies to solid tumors.

Authors:  James D Byrne; Mohammad R N Jajja; Adrian T O'Neill; Lissett R Bickford; Amanda W Keeler; Nabeel Hyder; Kyle Wagner; Allison Deal; Ryan E Little; Richard A Moffitt; Colleen Stack; Meredith Nelson; Christopher R Brooks; William Lee; J Chris Luft; Mary E Napier; David Darr; Carey K Anders; Richard Stack; Joel E Tepper; Andrew Z Wang; William C Zamboni; Jen Jen Yeh; Joseph M DeSimone
Journal:  Sci Transl Med       Date:  2015-02-04       Impact factor: 17.956

4.  Microprocessor in controlled transdermal drug delivery of anti-cancer drugs.

Authors:  N S Chandrashekar; R H Shobha Rani
Journal:  J Mater Sci Mater Med       Date:  2008-07-01       Impact factor: 3.896

5.  Transport numbers in transdermal iontophoresis.

Authors:  Blaise Mudry; Richard H Guy; M Begoña Delgado-Charro
Journal:  Biophys J       Date:  2006-01-27       Impact factor: 4.033

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.